InClinica

InClinica is a global research consulting, clinical development, and manufacturing company, specializing in helping early stage companies.

[InClinica @InClinica]

A recent study has found that allowing patients in #clinicaltrials to write, in their own words, about treatment-related symptoms provides invaluable information. Discover how this new research represents innovative data collection, via @medical_xpress.
https://t.co/mHaRoeTztM

[InClinica @InClinica]

#ICYMI: InClinica CEO Jim Nolan was featured in PharmaTech’s coverage of the government shutdown's impact on the FDA. Read more about the critical problems Jim sees regarding limited funding and the #FDA.
https://t.co/SV9FoQ8XdO

[InClinica @InClinica]

A blood pressure drug, losartan, has been recalled after small amounts of a carcinogen have been detected. Learn more about how this tainted medication was distributed from @USAToday.
https://t.co/I9AThKMyW3

[InClinica @InClinica]

The FDA, CDC, and CMS have joined forces as an interagency task force to guide the deployment of in vitro diagnostic tests during #publichealth emergencies. Read more from @FierceBiotech about this collaboration.
https://t.co/OXMO6MKtHI

[InClinica @InClinica]

New research has pinpointed gene regions that are associated with sleeplessness, which suggests that #insomnia can be inherited. Discover how these findings can spark new ideas for insomnia therapies, as well as associated risk factors from @FiercePharma.
https://t.co/Zz7HNAH9vG

[InClinica @InClinica]

The #FDA is in the process of accumulating research to update current regulations for #sunscreen products in order to make them safer and more effective. Learn more about current recommendations for consumers via @Pharmacist.
https://t.co/LD2nBIF6G9

[InClinica @InClinica]

#FDA Commissioner Scott Gottlieb said yesterday that he'd resign at the end of March. Dr. Gottlieb was focused on public health challenges, including the #opioid epidemic and drug prices. Learn more about his time as commissioner from @nytimes.
https://t.co/8aYdjr7BH6

[InClinica @InClinica]

In an effort to combat inflated #drugprices, one congressman has proposed a bill that would make it legal for patients to import #insulin from Canada. Read more from @FiercePharma about how this could help counteract the pricing monopoly.
https://t.co/8hARqRKwDe

[InClinica @InClinica]

The #FDA recently published a new guidance outlining regulatory considerations for a groundbreaking technology – an interface that links brains and computers. Learn more from @FierceBiotech about this innovation.
https://t.co/OHw5a6htCw

[InClinica @InClinica]

New research has pinpointed gene regions that are associated with sleeplessness, which suggests that #insomnia can be inherited. Discover how these findings can spark new ideas for insomnia therapies, as well as associated risk factors from @FiercePharma.
https://t.co/Zz7HNAH9vG

[InClinica @InClinica]

In case you missed it, CEO Jim Nolan was featured on episode 53 of @ROIConsult's Into the Corner Office podcast. Jim speaks about his background, interests and what led him to develop InClinica. Check it out below. #drugdevelopment #entrepreneurship
https://t.co/a7zrL1xpiX

[InClinica @InClinica]

According to @CancerNetwork, only 3 to 5 percent of eligible adult #cancer patients are enrolled in #clinicaltrials. Learn more about how this low participation contributes to increased costs of treatment and delays in progress of research.
https://t.co/2CgyKbXVF3

[InClinica @InClinica]

The #FDA took action to prevent the sale and marketing of potentially harmful products which are often distributed as dietary supplements. Learn more from @EverydayHealth about the steps taken to further prevent the circulation of these supplements.
https://t.co/fA3bHTZvZb

[InClinica @InClinica]

Researchers recently found enzymes in #HIV medications may be helpful for other conditions, such as age-related disorders. Learn more from @FierceBioTech on how this medication can help combat the effects of illnesses such as Alzheimer’s in the elderly.
https://t.co/V2SpdXlmIX

[InClinica @InClinica]

Genetic testing company @23andMe has quickly evolved into a force for medical research. Discover more from @NBC on how 23andMe has utilized its bank of genetic data to study links in various #medical conditions.
https://t.co/vGEazLbBS8

[InClinica @InClinica]

Research has shown that teens who start #vaping are about three times more likely to eventually smoke cigarettes than their peers. Check out this study from @TheVerge and why these results are alarming for both medical experts and the e-cigarette industry. https://t.co/CTyommZxda

[InClinica @InClinica]

CEO Jim Nolan was featured on episode 53 of @ROIConsult's Into the Corner Office podcast. Learn all about Jim's background, interests and how he came to be CEO of several companies. Check it out.
https://t.co/R3NtrYVizh

[InClinica @InClinica]

A new study has discovered additional information about how the gut may help to diagnose and even slow down the progression of #Parkinson’s disease. Read more about how gut health may aid in early detection and treatment, via @MedicalNewsToday. https://t.co/nkYS52iNss

[InClinica @InClinica]

The #FDA just suggested the use of #blockchain to improve traceability of pharmaceutical resources. Learn more from @CoinTelegraph about this innovative program and how it will improve drug supply chain security.
https://t.co/lUzKennwbg

[InClinica @InClinica]

A recent study found that weight loss, nutrient boosting and fat reduction diets can all reduce symptoms of #depression. Read more from @ScienceDaily about the influence of dietary improvement on #mentalhealth.
https://t.co/2istRdudhX